N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.168 NOK 1.59% Market Closed
Market Cap: 708m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nykode Therapeutics ASA
Operating Income Peer Comparison

Comparables:
HBC
B
BGBIO
L
LYTIX
AZT
T
TRMED

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
Operating Income
-$58.9m
CAGR 3-Years
N/A
CAGR 5-Years
-64%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Operating Income
-kr120.4m
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-14%
B
Bergenbio ASA
OSE:BGBIO
Operating Income
-kr162.2m
CAGR 3-Years
20%
CAGR 5-Years
3%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Operating Income
-kr96.8m
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Operating Income
kr7.9m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Operating Income
-kr20.3m
CAGR 3-Years
63%
CAGR 5-Years
44%
CAGR 10-Years
7%

See Also

What is Nykode Therapeutics ASA's Operating Income?
Operating Income
-58.9m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Operating Income amounts to -58.9m USD.

What is Nykode Therapeutics ASA's Operating Income growth rate?
Operating Income CAGR 5Y
-64%

Over the last year, the Operating Income growth was 3%.

Back to Top